Please login to the form below

Not currently logged in
Email:
Password:

pneumonia

This page shows the latest pneumonia news and features for those working in and with pharma, biotech and healthcare.

Roche’s Actemra fails in late-stage severe COVID-19 study

Roche’s Actemra fails in late-stage severe COVID-19 study

Actemra (tocilizumab) did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe COVID-19 associated pneumonia in the phase 3 COVACTA study. ... We will continue to generate evidence to provide a more

Latest news

More from news
Approximately 4 fully matching, plus 103 partially matching documents found.

Latest Intelligence

  • As COVID-19 takes over the world, biopharma fights back As COVID-19 takes over the world, biopharma fights back

    Prior research has suggested that elevated IL-6 levels are associated with a higher mortality rate in people with community-acquired pneumonia.

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    It is associated with serious illnesses such as cystic fibrosis and causes severe infections including pneumonia and urinary tract infections. ... The consequences of such severe infections include drug-resistant pneumonia and sepsis, and often prove

  • We’ll need more than a spoonful of sugar to counter vaccine hesitancy We’ll need more than a spoonful of sugar to counter vaccine hesitancy

    This trend in lower uptake of MMR vaccine has been observed worldwide, along with a 30% increase in measles cases globally, and the sequelae of this infection – deaths, pneumonia and encephalitis.

  • AI UK – one year on AI UK – one year on

    2. This study focused on the use of chest x-rays to diagnose pneumonia and compared three different approaches: using individual physicians alone; using an algorithm previously proven to have outperformed

  • The good, the bad and the ugly The good, the bad and the ugly

    This was driven largely by higher-than-expected sales of its pneumonia vaccine, Prevnar, which accounted for more than 11% of its total revenues in the third quarter of 2017.

More from intelligence
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a full cycle digital agency with 10 years expertise in developing content for the global pharmaceutical market delivering...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics